13-valent pneumococcal conjugate vaccines(Adult)
Adult
Prevenar 13
Provider:
PRIZER
Certification:
FDA & EMA & Hong Kong Department of Health
Suggested age:
Adult
Disease Prevention:
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
Side Effect:
Mild redness and swelling at injection site
Interval:
Adult: 1 dose
Precautions:
-
Characteristics: Contain extra strains of protection over Prevnar and Synflorix.
-
Peak Incidence age: Below 5 and Above 65 years old
-
High Risk Groups: Immunodeficient individual, Functional or anatomic asplenia, Cochlear implants
-
Contraindication: Severe allergic reaction (e.g. anaphylaxis) to any component of Prevnar 13 or any diphtheria toxoid-containing vaccine